Cargando…
Barriers to receiving testosterone replacement therapy in the community during COVID-19 pandemic
BACKGROUND: While the etiology for the upsurge in testosterone testing and prescriptions is likely multifactorial, increased direct-to-consumer marketing and the expansion of clinical care centers devoted to testosterone treatment likely play a role. Many of these centers require patients to report,...
Autores principales: | Troesch, Victoria L., Juhr, Denise, Pearlman, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421835/ https://www.ncbi.nlm.nih.gov/pubmed/34532255 http://dx.doi.org/10.21037/tau-21-350 |
Ejemplares similares
-
Testosterone deficiency in men receiving immunotherapy for malignant melanoma
por: Peters, Madeline, et al.
Publicado: (2021) -
Testosterone replacement therapy
por: Shoskes, Daniel A., et al.
Publicado: (2016) -
Testosterone Replacement Therapy
por: Hellstrom, Wayne J.G.
Publicado: (2004) -
COVID-19 Infection in Men on Testosterone Replacement Therapy
por: Rambhatla, Amarnath, et al.
Publicado: (2020) -
Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)